Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
出版年份 2021 全文链接
标题
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
作者
关键词
-
出版物
LEUKEMIA
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-06-25
DOI
10.1038/s41375-021-01328-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dimeric ferrochelatase bridges ABCB7 and ABCB10 homodimers in an architecturally defined molecular complex required for heme biosynthesis
- (2019) Nunziata Maio et al. HAEMATOLOGICA
- Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
- (2019) Tyler B. Faust et al. Nature Chemical Biology
- Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management
- (2019) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations
- (2018) Andrea Pellagatti et al. BLOOD
- The cryo-EM structure of the SF3b spliceosome complex bound to a splicing modulator reveals a pre-mRNA substrate competitive mechanism of action
- (2018) Lorenzo I. Finci et al. GENES & DEVELOPMENT
- H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
- (2018) Michael Seiler et al. NATURE MEDICINE
- Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia
- (2018) Yusuke Shiozawa et al. Nature Communications
- Modeling SF3B1 Mutations in Cancer: Advances, Challenges, and Opportunities
- (2016) Daichi Inoue et al. CANCER CELL
- Physiologic Expression of Sf3b1 K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation
- (2016) Esther A. Obeng et al. CANCER CELL
- Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
- (2016) Stanley Chun-Wei Lee et al. NATURE MEDICINE
- An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults
- (2015) M. R. Savona et al. BLOOD
- Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study
- (2015) Lene Sofie Granfeldt Østgård et al. JOURNAL OF CLINICAL ONCOLOGY
- Graphical representation of clinical outcomes for patients with myelodysplastic syndromes
- (2015) David P. Steensma LEUKEMIA & LYMPHOMA
- Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable
- (2014) Katerina Zoi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- TMEM14C is required for erythroid mitochondrial heme metabolism
- (2014) Yvette Y. Yien et al. JOURNAL OF CLINICAL INVESTIGATION
- Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells
- (2014) H Dolatshad et al. LEUKEMIA
- A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors
- (2013) D. S. Hong et al. INVESTIGATIONAL NEW DRUGS
- Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
- (2012) F. Damm et al. BLOOD
- Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
- (2012) H. Makishima et al. BLOOD
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Splicing factor mutations in myelodysplasia
- (2012) Seishi Ogawa INTERNATIONAL JOURNAL OF HEMATOLOGY
- Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
- (2011) L. Malcovati et al. BLOOD
- The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region
- (2011) E. G. Folco et al. GENES & DEVELOPMENT
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
- (2011) Timothy A Graubert et al. NATURE GENETICS
- SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts
- (2011) E. Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now